Phototransformation of Amlodipine
References
1. Azzouz A, Ballesteros E (2013) Influence of seasonal climate differences on the
pharmaceutical, hormone and personal care product removal efficiency of a
drinking water treatment plant. Chemosph 93: 2046–2054.
2. Santos LH, Arau`jo AN, Fachini A, Pena A, Delerue-Matos C, et al. (2010)
Ecotoxicological aspects related to the presence of pharmaceuticals in the
aquatic environment: review. J Hazard Mater 175: 45–95.
3. Collado N, Buttiglieri G, Ferrando L, Climent, Rodriguez-Mozaz S, et al. (2012)
Removal of ibuprofen and its transformation products: Experimental and
simulation studies. Sci Total Environ 433: 296–301.
4. Ille´s E, Taka´cs E, Dombi A, Gajda-Schrantz K, Ra´cz G, et al. (2013) Hydroxyl
radical induced degradation of ibuprofen. Sci Total Environ 447: 286–292.
5. Halling-Sørensen B, Sengelo¨v G, Tjo¨rnelund J (2002) Toxicity of tetracyclines
and tetracycline degradation products to environmentally relevant bacteria,
including selected tetracycline-resistant bacteria. Arch Environ Contam Toxicol
42: 263–271.
6. Boxall AB, Sinclair CJ, Fenner K, Kolpin D, Maund SJ (2004) When synthetic
chemicals degrade in the environment. Environ Sci Technol 38: 368A–375A.
7. Naidu HR, Kale UN, Shingare MS (2005) Stability indicating RPHPLC method
for simultaneous determination of amlodipine and benazepril hydrochloride
from their combination drug product. J Pharm Biomed Anal 39: 147–155.
8. Eranki RJV, Inti G, Jayaraman V, Pannala R, Vidiyala SR, et al. (2013) New
Stability Indicating Method for Quantification of Impurities in Amlodipine and
Benazepril Capsules by Validated HPLC. Amer J Anal Chem 4: 715–724.
9. Yu Q, Hu Z-Y, Zhu F-Y, Zhu J-H, Wan L-L, et al. (2011) HPLC–MS–MS for
the Simultaneous Determination of Atorvastatin and Amlodipine in Plasma of
Hypertensive Patients. Chromatograph 73: 257–262.
10. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence,
awareness, treatment, and control of hypertension among United States adults
1999–2004. Hypertension 49: 69–75.
11. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005)
Global burden of hypertension: analysis of worldwide data. Lancet 365: 217–
223.
and advanced oxidation processes – Degradation, elucidation of byproducts and
assessment of their biological potency. Chemosph 85: 693–709.
22. Michael I, Vasquez MI, Hapeshi E, Haddad T, Baginska E, et al. (2014)
Metabolites and transformation products of pharmaceuticals in the aquatic
environment as contaminants of emerging concern. In: Lambropoulou DA,
Nollet LML, editors. Advanced Mass Spectrometry-based techniques for the
identification and structure elucidation of transformation products of emerging
contaminants: Wiley. pp. 413–459.
23. Boreen AL, Arnold WA, McNeil K (2003) Photodegradation of pharmaceutical
in the aquatic environment: A review. Aquat Sci 65: 320–341.
24. Lin AYC, Reinhard M (2005) Photodegradation of common environmental
pharmaceuticals and estrogens in river water. Environ Toxicol Chem 24: 1303–
1309.
25. Alapi T, Dombi A (2007) Comparative study of the UV and UV/VUV
photolysis of phenol in aqueous solution. J Photchem Photobiol A 188: 409–418.
26. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and
their solar photodegradation in aquatic envi-ronment. Chemosph 50: 1319–
1330.
27. Krauss M, Singer H, Hollender J (2010) LC-high resolution MS in
environmental analysis: from target screening to the identification of unknowns.
Anal Bioanal Chem 397: 943–951.
28. Kosjek T, Heath E, Petrovic M, Barcelo D (2007) Mass spectrometry for
identifying pharmaceutical biotransformation products in the environment.
Trends Anal Chem 26: 1076–1085.
´
´
´
´
29. Jakimska A, Sliwka-Kaszynska M, Reszczynska J, Namiesnik J, Kot-Wasik A
(2014) Elucidation of transformation pathway of ketoprofen, ibuprofen, and
furosemide in surface water and their occurrence in the aqueous environment
using UHPLC-QTOF-MS. Anal Bioanal Chem 406: 3667–3680.
30. Go´rska P, Zaleska A, Hupka J (2009) Photodegradation of phenol by UV/TiO2
and Vis/N,C-TiO2 processes: Comparative mechanistic and kinetic studies. Sep
Purif Technol 68: 90–96.
12. Kreutz R (2011) Olmesartan/amlodipine: a review of its use in the management
of hypertension. Vasc Health Risk Manage 7: 183–192.
31. Lin AYC, Reinhard M (2005) Photodegradation of common environmental
pharmaceuticals and estrogens in river water. Environ Toxicol Chem 24: 1303–
1309.
13. Qi W, Zhao Q, Jiang J, Hu P (2013) Simultaneous determination of olmesartan
and amlodipine in human plasma and urine by ultra performance liquid
chromatography tandem mass spectrometry. J Chromatogr B 938: 27–34.
14. Santos LHMLM, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, et al.
(2013) Contribution of hospital effluents to the load of pharmaceuticals in urban
wastewaters: Identification of ecologically relevant pharmaceuticals. Sci Total
Environ 462: 302–316.
15. Pascoe D, Karntanut W, Muller CT (2003) Do pharmaceuticals affect
freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosph
51: 521–528.
16. DellaGreca M, Iesce MR, Isidori M, Montanaro S, Previtera L, et al. (2007)
Phototransformation of Amlodipine in Aqueous Solution: Toxicity of the Drug
and Its Photoproduct on Aquatic Organisms. Internat J Photoen 2007: 1–6.
17. Fasani E, Albini A, Gemme S (2008) Mechanism of the photochemical
degradation of amlodipine. Int J Pharmaceut 352: 197–201.
18. Ragno G, Garofalo A, Vetuschi C (2002) Photodegradation monitoring of
amlodipine by derivative spectrophotometry. J Pharm Biomed Anal 27: 19–24.
19. Devi ASL, Rao YS, Satish M, Jyothi G, Rao KB, et al. (2007) Structure
elucidation of thermal degradation products of amlodipine. Magn Reson Chem
45: 688–691.
20. Damale S, Bhandarkar D, Raju S, Rane S, Kochhar R, et al. (2013)
Characterization of products formed by forced degradation of amlodipine
besylate using LC/MS/MS: Shimatdzu Application note.
32. Huntscha S, Hofstetter TB, Schymanski EL, Spahr S, Hollender J (2014)
Biotransformation of Benzotriazoles: Insights from Transformation Product
Identification and Compound-Specific Isotope Analysis. Environ Sci Technol
48: 4435–4443.
33. Schymanski EL, Jeon J, Gulde R, Fenner K, Ruff M, et al. (2014) Identifying
Small Molecules via High Resolution Mass Spectrometry: Communicating
Confidence. Environ Sci Technol 48: 2097–2098.
34. Kim I, Tanaka H (2009) Photodegradation characteristics of PPCPs in water
with UV treatment. Environ Internat 35: 793–802.
´
35. Gros M, Rodrıguez-Mozaz S, Barcelo´ D (2012) Fast and comprehensive multi-
residue analysis of a broad range of human and veterinary pharmaceuticals and
some of their metabolites in surface and treated waters by ultra-high-
performance liquid chromatography coupled to quadrupole-linear ion trap
tandem mass spectrometry. J Chromatogr A 1248: 104–121.
36. Yan Q, Gao X, Chen YP, Peng XY, Zhang YX, et al. (2014) Occurrence, fate
and ecotoxicological assessment of pharmaceutically active compounds in
wastewater and sludge from wastewater treatment plants in Chongqing, the
Three Gorges Reservoir Area. Sci Total Environ 470–471: 618–630.
37. Horsing M, Ledin A, Grabic R, Fick J, Tysklind M, et al. (2011) Determination
of sorption of seventy-five pharmaceuticals in sewage sludge. Wat Res 45: 4470–
4482.
38. US EPA (2014) Estimation Programs Interface Suite for Microsoft Windows, v
4.11]. United States Environmental Protection Agency, Washington, DC, USA.
21. Fatta-Kassinos D, Vasquez MI, Ku¨mmerer K (2011) Transformation products
of pharmaceuticals in surface waters and wastewater formed during photolysis
10
October 2014 | Volume 9 | Issue 10 | e109206